Use of Flecainide in Stable Coronary Artery Disease: An Analysis of Its Safety in Both Nonobstructive and Obstructive Coronary Artery Disease
ConclusionFlecainide use is not associated with an increase in either all-cause mortality or ventricular arrhythmias in low-risk patients with stable nonobstructive CAD.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Angiography | Arrhythmia | Cardiology | Cardiovascular | Heart | Heart Attack | Perfusion